Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Tesa Ipa Blend and BAC Water Mix

Tesa Ipa Blend Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Tesa Ipa Blend Titration Schedule

CompoundPer-DoseNote
Tesamorelin0.5–2 mgFDA-approved molecule; label = 2 mg daily continuous
Ipamorelin100–500 mcgMost selective GHRP; Ph2 failed
Cycles8–12 wks / 4–8 offNo blend studies exist

Component ranges accurate; the blend itself has zero studies. Notable: the blend underdoses tesamorelin versus its own label (2 mg daily continuous for HIV lipodystrophy), and ipamorelin's development ended with a failed Phase 2 in 2014.

Possible vial strengths:

What Is It?

Tesa Ipa Blend

Tesamorelin + ipamorelin research blend.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Tesa Ipa Blend

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Tesa Ipa Blend Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

It pairs two different growth-hormone peptides: tesamorelin (a GHRH analog) and ipamorelin (a GHRP), which act on separate receptors. People combine them because the two signals work through different pathways, not because they're one drug.
Each compound is calculated on its own: tesamorelin in milligrams (around 1–2 mg), ipamorelin in micrograms (around 100–300 mcg). How they're paired is a clinical decision — a calculator shouldn't merge two different doses into one number.
If it's one combined vial, reconstitute it whole, then read each peptide off its own amount. Example: a vial with 10 mg tesamorelin + 5 mg ipamorelin in 2 mL = 5 mg/mL tesa and 2.5 mg/mL ipa; 2 mg tesa = 0.4 mL (40 units). Use the calculator above for your exact contents.
Tesamorelin pushes the pituitary through the GHRH receptor; ipamorelin pushes it through the ghrelin receptor, with little appetite or cortisol effect. The idea is two complementary signals — but combining is a clinical choice, and each still has its own dose, timing, and risks.
Only tesamorelin is FDA-approved (Egrifta, for HIV-linked belly fat); ipamorelin is investigational, and no blend is approved. Because both raise GH/IGF-1, active cancer is a contraindication. Store the dry vial cold and dark; once mixed, refrigerate and use within a few weeks.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides